Vol 2, No 1 (2013)
Review article
Published online: 2013-04-10
Page views
596
Article views/downloads
5840
Individualization of oral antidiabetic therapy in patients with type 2 diabetes
Diabetologia Kliniczna 2013;2(1):14-22.
Abstract
Diabetes causes signifi cant deterioration in the quality
of life and contributes signifi cantly to shorten survival.
Therefore, efforts should be made to in the fi rst place
to prevent or delay the onset of diabetes, and after
diagnosis of the disease as effectively as possible to
treat it. Treatment of diabetic patients must be individualized. The individualized management of patients
with diabetes, including patients with type 2 diabetes
should be considered to prevent or delay the onset
of diabetes including type 2 diabetes, set individual
targets for the treatment of diabetes and very carefully
selected medications for diabetes, blood pressure-
-lowering and lipid-lowering taking into account the
needs of clinical patient.
of life and contributes signifi cantly to shorten survival.
Therefore, efforts should be made to in the fi rst place
to prevent or delay the onset of diabetes, and after
diagnosis of the disease as effectively as possible to
treat it. Treatment of diabetic patients must be individualized. The individualized management of patients
with diabetes, including patients with type 2 diabetes
should be considered to prevent or delay the onset
of diabetes including type 2 diabetes, set individual
targets for the treatment of diabetes and very carefully
selected medications for diabetes, blood pressure-
-lowering and lipid-lowering taking into account the
needs of clinical patient.
Keywords: type 2 diabetesoral antidiabetic agentsindividualization procedure